$What you should know about the new study titled: “Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus”.$

In Home Page Articles, Links to Lupus News

Posted October 27, 2022

What you should know about the new study titled: “Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus”.

Paper Reviewed by Dr Andrew R Benck and Dr Dmitriy Cherny (Rush Lupus Clinic) The causes of lupus are complex, but it is known that a type of immune cell called [...]

Higher quality of care fails to improve quality of life in lupus

Published article from Helio https://www.healio.com/news/rheumatology/20220825/higher-quality-of-care-fails-to-improve-quality-of-life-in-lupus Patients with systemic lupus erythematosus who [...]

Does hydroxychloroquine improve patient reported outcomes in patients with lupus?

LSI Medical Advisory Board member and Director of the RUSH Lupus Clinic Dr. Meenakshi Jolly lead an investigation on Hydroxychloroquine (HCQ) use and patient reported outcomes. The research [...]